ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/09/30 | 2,861 | 2,877 | 2,825 | 2,865 | -40 | -1.4% | 286,000 |
2016/09/29 | 2,905 | 2,914 | 2,870 | 2,905 | -4 | -0.1% | 318,000 |
2016/09/28 | 2,930 | 2,937 | 2,893 | 2,909 | -53 | -1.8% | 264,500 |
2016/09/27 | 2,881 | 2,962 | 2,866 | 2,962 | +31 | +1.1% | 328,200 |
2016/09/26 | 2,950 | 2,957 | 2,930 | 2,931 | -11 | -0.4% | 218,400 |
2016/09/23 | 2,887 | 2,944 | 2,856 | 2,942 | +25 | +0.9% | 389,600 |
2016/09/21 | 2,836 | 2,922 | 2,827 | 2,917 | +72 | +2.5% | 361,800 |
2016/09/20 | 2,816 | 2,850 | 2,787 | 2,845 | +7 | +0.2% | 226,900 |
2016/09/16 | 2,841 | 2,847 | 2,814 | 2,838 | -3 | -0.1% | 224,300 |
2016/09/15 | 2,790 | 2,858 | 2,788 | 2,841 | +24 | +0.9% | 299,500 |
2016/09/14 | 2,829 | 2,838 | 2,802 | 2,817 | -14 | -0.5% | 219,800 |
2016/09/13 | 2,795 | 2,887 | 2,791 | 2,831 | +64 | +2.3% | 401,400 |
2016/09/12 | 2,786 | 2,802 | 2,759 | 2,767 | -43 | -1.5% | 189,300 |
2016/09/09 | 2,817 | 2,836 | 2,782 | 2,810 | -1 | ±0% | 295,000 |
2016/09/08 | 2,803 | 2,816 | 2,767 | 2,811 | +14 | +0.5% | 262,000 |
2016/09/07 | 2,789 | 2,820 | 2,771 | 2,797 | +31 | +1.1% | 265,900 |
2016/09/06 | 2,742 | 2,769 | 2,730 | 2,766 | +30 | +1.1% | 268,200 |
2016/09/05 | 2,741 | 2,749 | 2,707 | 2,736 | +6 | +0.2% | 170,200 |
2016/09/02 | 2,717 | 2,750 | 2,706 | 2,730 | -19 | -0.7% | 293,300 |
2016/09/01 | 2,714 | 2,752 | 2,683 | 2,749 | +25 | +0.9% | 293,900 |
2016/08/31 | 2,753 | 2,753 | 2,675 | 2,724 | -31 | -1.1% | 303,700 |
2016/08/30 | 2,760 | 2,763 | 2,716 | 2,755 | +6 | +0.2% | 202,500 |
2016/08/29 | 2,805 | 2,805 | 2,740 | 2,749 | -27 | -1% | 278,400 |
2016/08/26 | 2,810 | 2,810 | 2,771 | 2,776 | -53 | -1.9% | 150,000 |
2016/08/25 | 2,848 | 2,848 | 2,805 | 2,829 | -39 | -1.4% | 202,800 |
2016/08/24 | 2,840 | 2,876 | 2,805 | 2,868 | +64 | +2.3% | 325,400 |
2016/08/23 | 2,778 | 2,820 | 2,768 | 2,804 | -8 | -0.3% | 391,100 |
2016/08/22 | 2,794 | 2,816 | 2,770 | 2,812 | +1 | ±0% | 207,400 |
2016/08/19 | 2,803 | 2,814 | 2,781 | 2,811 | -2 | -0.1% | 184,700 |
2016/08/18 | 2,811 | 2,838 | 2,789 | 2,813 | -28 | -1% | 221,300 |
2016/08/17 | 2,876 | 2,877 | 2,829 | 2,841 | -55 | -1.9% | 260,200 |
2016/08/16 | 2,949 | 2,949 | 2,876 | 2,896 | -57 | -1.9% | 283,300 |
2016/08/15 | 2,975 | 2,975 | 2,929 | 2,953 | -52 | -1.7% | 161,000 |
2016/08/12 | 2,957 | 3,010 | 2,950 | 3,005 | +70 | +2.4% | 210,900 |
2016/08/10 | 2,990 | 2,990 | 2,925 | 2,935 | -90 | -3% | 378,800 |
2016/08/09 | 3,000 | 3,030 | 2,957 | 3,025 | -5 | -0.2% | 432,800 |
2016/08/08 | 3,050 | 3,065 | 2,990 | 3,030 | +15 | +0.5% | 496,600 |
2016/08/05 | 2,970 | 3,075 | 2,955 | 3,015 | +305 | +11.3% | 904,200 |
2016/08/04 | 2,767 | 2,770 | 2,685 | 2,710 | -57 | -2.1% | 315,200 |
2016/08/03 | 2,800 | 2,802 | 2,752 | 2,767 | -101 | -3.5% | 198,900 |
2016/08/02 | 2,885 | 2,916 | 2,866 | 2,868 | -50 | -1.7% | 125,400 |
2016/08/01 | 2,887 | 2,945 | 2,843 | 2,918 | +8 | +0.3% | 230,100 |
2016/07/29 | 2,897 | 2,924 | 2,800 | 2,910 | +53 | +1.9% | 284,000 |
2016/07/28 | 2,868 | 2,904 | 2,846 | 2,857 | -5 | -0.2% | 207,600 |
2016/07/27 | 2,880 | 2,903 | 2,842 | 2,862 | -3 | -0.1% | 120,300 |
2016/07/26 | 2,860 | 2,873 | 2,819 | 2,865 | +14 | +0.5% | 200,400 |
2016/07/25 | 2,890 | 2,895 | 2,834 | 2,851 | -38 | -1.3% | 168,600 |
2016/07/22 | 2,842 | 2,892 | 2,836 | 2,889 | +25 | +0.9% | 150,400 |
2016/07/21 | 2,896 | 2,896 | 2,842 | 2,864 | +12 | +0.4% | 141,300 |
2016/07/20 | 2,840 | 2,867 | 2,822 | 2,852 | +9 | +0.3% | 226,300 |
2101~
2150
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 434,700円 | +20.9% | +87.3% | 3.13% | 9.71倍 | 1.12倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
住友ファーマ | 96,400円 | +26.8% | - | 0.00% | 16.23倍 | 3.35倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 436,500円 | +5.8% | +1.2% | 2.75% | 14.48倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 191,600円 | +5.0% | +1.5% | 0.00% | 16.45倍 | 4.38倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 336,300円 | +8.0% | -15.3% | 3.69% | 9.44倍 | 0.92倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム